These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 36207960)
1. [Research advances in post-tuberculosis lung disease]. Deng MH; Zhang SY; Wang Y Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):1041-1045. PubMed ID: 36207960 [TBL] [Abstract][Full Text] [Related]
2. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Allwood BW; Byrne A; Meghji J; Rachow A; van der Zalm MM; Schoch OD Respiration; 2021; 100(8):751-763. PubMed ID: 33401266 [TBL] [Abstract][Full Text] [Related]
3. [Post-tuberculosis lung disease: a neglected disease]. Ma Y; Ye XP; Fu XY; Wu GH Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):955-959. PubMed ID: 36207951 [TBL] [Abstract][Full Text] [Related]
4. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793 [TBL] [Abstract][Full Text] [Related]
5. Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey. Khedmat H; Taheri S Hematol Oncol Stem Cell Ther; 2011; 4(1):10-6. PubMed ID: 21460602 [TBL] [Abstract][Full Text] [Related]
6. Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey. Izadi M; Taheri S Prog Transplant; 2011 Dec; 21(4):353-9. PubMed ID: 22549000 [TBL] [Abstract][Full Text] [Related]
7. The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases. Wood BL; Sabath D; Broudy VC; Raghu G Cancer; 1996 Nov; 78(10):2223-8. PubMed ID: 8918418 [TBL] [Abstract][Full Text] [Related]